RS Investment Management’s Kite Pharma, Inc. KITE Stock Holding History

RS Investment Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$22.7M	Sell	453,501 -38,937	-8%	-$1.91M	0.23%	162
2016 Q1	$22.6M	Buy	492,438 +7,387	+2%	+$358K	0.22%	158
2015 Q4	$29.9M	Sell	485,051 -99,509	-17%	-$7M	0.27%	131
2015 Q3	$32.5M	Buy	584,560 +137,120	+31%	+$8.62M	0.29%	124
2015 Q2	$27.3M	Buy	447,440 +194,330	+77%	+$11.1M	0.23%	156
2015 Q1	$14.6M	Sell	253,110 -63,300	-20%	-$4.24M	0.13%	211
2014 Q4	$18.2M	Buy	+316,410	New	+$13.3M	0.16%	204

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

RS Investment Management's KITE Position: Q2 2016 in Review

RS Investment Management reduced its Kite Pharma, Inc. (KITE) stake by 7.9% in Q2 2016, selling an estimated $1.91M and leaving 453,501 shares worth $22.7M. The position accounts for 0.23% of the portfolio, ranked #162.

RS Investment Management first reported a position in KITE in Q4 2014 and has held it in 7 quarters since. The position peaked at $32.5M in Q3 2015. 173 funds tracked by Wall St. Rank hold KITE as of Q2 2016.

RS Investment Management held 453,501 shares of Kite Pharma, Inc. worth $22.7M as of Q2 2016.
RS Investment Management sold 38,937 Kite Pharma, Inc. shares in Q2 2016, an estimated $1.91M.
Kite Pharma, Inc. made up 0.23% of RS Investment Management's portfolio in Q2 2016, its #162 holding.
RS Investment Management first reported a position in Kite Pharma, Inc. in Q4 2014 and has held it in 7 quarters since.
RS Investment Management's Kite Pharma, Inc. position peaked at $32.5M in Q3 2015.
173 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.